81 related articles for article (PubMed ID: 7711159)
1. Basal and haloperidol-stimulated prolactin and symptoms of nonaffective and affective psychoses in neuroleptic-free men.
Keks NA; Copolov DL; McKenzie DP; Kulkarni J; Hill C; Hope JD; Singh BS
Biol Psychiatry; 1995 Feb; 37(4):229-34. PubMed ID: 7711159
[TBL] [Abstract][Full Text] [Related]
2. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological treatment of delusional depression].
Amore M; Giordani L; Giorgetti G; Zazzeri N
Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
[TBL] [Abstract][Full Text] [Related]
4. Multidiagnostic evaluation of prolactin response to haloperidol challenge in schizophrenia: maximal blunting in Kraepelinian patients.
Keks NA; McKenzie DP; Low LH; McGorry PD; Hill C; Kulkarni J; Singh BS; Copolov DL
Biol Psychiatry; 1992 Sep; 32(5):426-37. PubMed ID: 1486148
[TBL] [Abstract][Full Text] [Related]
5. Prolactin response to neuroleptic challenge in late-life psychosis.
Sweet RA; Pollock BG; Mulsant BH; Rosen J; Henteleff RA
Psychopharmacol Bull; 1995; 31(4):651-7. PubMed ID: 8851636
[TBL] [Abstract][Full Text] [Related]
6. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R
Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227
[TBL] [Abstract][Full Text] [Related]
7. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
8. Prolactin response to low-dose haloperidol challenge in schizophrenic, non-schizophrenic psychotic, and control subjects.
Copolov DL; Keks NA; Kulkarni J; Singh BS; McKenzie D; McGorry P; Hill C
Psychoneuroendocrinology; 1990; 15(3):225-31. PubMed ID: 2255750
[TBL] [Abstract][Full Text] [Related]
9. Psychopathology factors in first-episode affective and non-affective psychotic disorders.
Salvatore P; Khalsa HM; Hennen J; Tohen M; Yurgelun-Todd D; Casolari F; Depanfilis C; Maggini C; Baldessarini RJ
J Psychiatr Res; 2007 Nov; 41(9):724-36. PubMed ID: 16762370
[TBL] [Abstract][Full Text] [Related]
10. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
11. Interictal psychoses in comparison with schizophrenia--a prospective study.
Tadokoro Y; Oshima T; Kanemoto K
Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
[TBL] [Abstract][Full Text] [Related]
12. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
13. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
14. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].
Chabrol H; Chouicha K; Montovany A; Callahan S
Encephale; 2001; 27(2):120-7. PubMed ID: 11407263
[TBL] [Abstract][Full Text] [Related]
15. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
[TBL] [Abstract][Full Text] [Related]
18. Prolactin response to submaximal stimulation by TRH in nonaffective psychoses.
Spoov J; Bredbacka PE; Appelberg B; Katila H; Karonen SL; Rimón R; Sarna S
Biol Psychiatry; 1991 Feb; 29(3):204-10. PubMed ID: 1673063
[TBL] [Abstract][Full Text] [Related]
19. Prolactin response in tardive dyskinesia.
Wolf ME; Bowie L; Keener S; Mosnaim AD
Biol Psychiatry; 1982 Apr; 17(4):485-90. PubMed ID: 7082714
[No Abstract] [Full Text] [Related]
20. Assessment and physical treatment of affective disorder.
Tyrer SP
Br J Hosp Med; 1989 Sep; 42(3):184-90, 192, 194. PubMed ID: 2571380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
